CS logo
small CS logo
Zhejiang Provincial Hospital of TCM

Hangzhou, Zhejiang, China
Hospital in Hangzhou
8 Fengqi Rd, Xiacheng District, Hangzhou, Zhejiang, 310020

About Zhejiang Provincial Hospital of TCM


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Heilongjiang University of Chinese Medicine
3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2
Shanghai Jiao Tong University School of Medicine
2
Betta Pharmaceuticals Co., Ltd.
1
Daiichi Sankyo, Inc.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University
1
Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
1
Shanghai Hutchison Pharmaceuticals Limited
1
Shanghai Yueyang Integrated Medicine Hospital
1
Shenyang Northern Hospital
1
Suodi ZHAI
1
Total Rows: 15

Clinical Trials at Zhejiang Provincial Hospital of TCM


During the past decade, Zhejiang Provincial Hospital of TCM conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
2009-07-01
2015-10-01
Terminated
102
Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine
2009-10-01
2013-12-01
Unknown status
660
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
2009-09-01
2014-08-01
Unknown status
420
Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome
2012-07-06
2015-10-07
Completed
1,000
Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease
2012-09-01
2016-07-01
Unknown status
180
A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
2011-07-01
2015-12-01
Unknown status
2,700
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
2014-01-01
Completed
30,400
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
2015-07-01
2023-12-01
Recruiting
970

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Zhejiang Provincial Hospital of TCM" #1 sponsor was "Heilongjiang University of Chinese Medicine" with 3 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored, "Shanghai Jiao Tong University School of Medicine" with 2 trials sponsored, "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zhejiang Provincial Hospital of TCM" #1 collaborator was "Jiangsu Province Hospital of Traditional Chinese Medicine" with 2 trials as a collaborator, "The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine" with 2 trials as a collaborator, "Zhejiang Provincial Hospital of TCM" with 2 trials as a collaborator, "Affiliated Hospital of Gansu University of traditional Chinese Medicine" with 1 trials as a collaborator and "Affiliated Yueqing Hospital of Wenzhou Medical University" with 1 trials as a collaborator. Other collaborators include 129 different institutions and companies that were collaborators in the rest 139 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHeilongjiang Universityof Chinese Medicine: 3Heilongjiang Universityof Chinese Medicine: 3Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 2Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 2Shanghai Jiao TongUniversity School ofMedicine: 2Shanghai Jiao TongUniversity School ofMedicine: 2Betta PharmaceuticalsCo., Ltd.: 1Betta PharmaceuticalsCo., Ltd.: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Second AffiliatedHospital, School ofMedicine, ZhejiangUniversity: 1Second AffiliatedHospital, School ofMedicine, ZhejiangUniversity: 1Shanghai HongyitangBiopharmaceuticalTechnology Co. Ltd.: 1Shanghai HongyitangBiopharmaceuticalTechnology Co. Ltd.: 1Shanghai HutchisonPharmaceuticalsLimited: 1Shanghai HutchisonPharmaceuticalsLimited: 1Shanghai YueyangIntegrated MedicineHospital: 1Shanghai YueyangIntegrated MedicineHospital: 1Shenyang Northern Hospital: 1Shenyang Northern Hospital: 1

Created with Highcharts 11.1.0Top CollaboratorsJiangsu ProvinceHospital of TraditionalChinese Medicine: 2Jiangsu ProvinceHospital of TraditionalChinese Medicine: 2The First AffiliatedHospital of AnhuiUniversity of TraditionalChinese Medicine: 2The First AffiliatedHospital of AnhuiUniversity of TraditionalChinese Medicine: 2Zhejiang ProvincialHospital of TCM: 2Zhejiang ProvincialHospital of TCM: 2Affiliated Hospital ofGansu University oftraditional ChineseMedicine: 1Affiliated Hospital ofGansu University oftraditional ChineseMedicine: 1Affiliated YueqingHospital of WenzhouMedical University: 1Affiliated YueqingHospital of WenzhouMedical University: 1Anhui ProvincialChildren's Hospital: 1Anhui ProvincialChildren's Hospital: 1Beijing Geriatric Hospital: 1Beijing Geriatric Hospital: 1Beijing Hospital ofTraditional ChineseMedicine: 1Beijing Hospital ofTraditional ChineseMedicine: 1Beijing Luhe Hospital,Capital MedicalUniversity: 1Beijing Luhe Hospital,Capital MedicalUniversity: 1Beijing University ofChinese Medicine: 1Beijing University ofChinese Medicine: 1

Clinical Trials Conditions at Zhejiang Provincial Hospital of TCM


According to Clinical.Site data, the most researched conditions in "Zhejiang Provincial Hospital of TCM" are "Polycystic Ovary Syndrome" (3 trials), "Adverse Drug Reaction" (1 trials), "Asthma" (1 trials), "Breast Cancer" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Zhejiang Provincial Hospital of TCM" in a lesser frequency.

Clinical Trials Intervention Types at Zhejiang Provincial Hospital of TCM


Most popular intervention types in "Zhejiang Provincial Hospital of TCM" are "Drug" (16 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Letrozole" (2 trials), "Acupuncture treatment 1" (1 trials), "Acupuncture treatment 2" (1 trials) and "Aspirin 100mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Zhejiang Provincial Hospital of TCM


The vast majority of trials in "Zhejiang Provincial Hospital of TCM" are 13 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Zhejiang Provincial Hospital of TCM


Currently, there are NaN active trials in "Zhejiang Provincial Hospital of TCM". 2 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Zhejiang Provincial Hospital of TCM, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Zhejiang Provincial Hospital of TCM, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 6Not Applicable: 6Phase 2: 5Phase 2: 5Phase 4: 3Phase 4: 3Phase 3: 2Phase 3: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusUnknown status: 7Unknown status: 7Completed: 5Completed: 5Recruiting: 3Recruiting: 3Not yet recruiting: 2Not yet recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1